Revalia Bio Revenue and Competitors
Estimated Revenue & Valuation
- Revalia Bio's estimated annual revenue is currently $5.9M per year.
- Revalia Bio's estimated revenue per employee is $190,000
- Revalia Bio's total funding is $12M.
Employee Data
- Revalia Bio has 31 Employees.
- Revalia Bio grew their employee count by 72% last year.
Revalia Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Chief Operating Officer & Co-founder | Reveal Email/Phone |
3 | Co-Founder & CSO | Reveal Email/Phone |
4 | Co-Founder & Chief Medical Officer | Reveal Email/Phone |
5 | Co-Founder & Chief Research Operations Officer | Reveal Email/Phone |
6 | Co-Founder & Chief Operating Officer | Reveal Email/Phone |
7 | Co-Founder & Chief Culture & Growth Officer | Reveal Email/Phone |
8 | Chief Research Operations Officer | Reveal Email/Phone |
9 | Principal Scientist, Data Generation | Reveal Email/Phone |
10 | Senior Organ Perfusion Researcher | Reveal Email/Phone |
Revalia Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | 0% | N/A | N/A |
#2 | $3.3M | 21 | -25% | N/A | N/A |
#3 | $9.8M | 81 | -10% | N/A | N/A |
#4 | $1.7M | 11 | 450% | N/A | N/A |
#5 | $20.3M | 131 | -23% | N/A | N/A |
#6 | $5.4M | 35 | -22% | N/A | N/A |
#7 | $2M | 13 | 44% | N/A | N/A |
#8 | $2.8M | 18 | 20% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $3.6M | 23 | -12% | N/A | N/A |
What Is Revalia Bio?
Revalia Bio is a forward-thinking technology startup revolutionizing drug discovery and development with a human-centric approach. We leverage critical human data to create innovative solutions that make drug discovery more accurate, efficient, and humane.\n\nOur groundbreaking “Human Organ Trials” provide deep insights into human biology, enabling rapid and agile drug development. These trials allow us to predict clinical outcomes faster, safer, and more cost-effectively than traditional methods, transforming how drugs are developed.\n\nUnlike traditional AI-driven drug development, which relies on limited data, our Human Organ Trials bridge the gap between preclinical testing and first-in-human trials, offering a clear path that aligns with the FDA's vision to modernize drug development.\n\nAt Revalia Bio, we are committed to mitigating the risks of drug development, accelerating the creation of safer, more effective therapies, and shortening clinical trial timelines from over a decade to less than a month. Our mission is to meet the urgent need for innovative approaches that improve patient outcomes, reduce costs, and ultimately save lives.
keywords:N/A$12M
Total Funding
31
Number of Employees
$5.9M
Revenue (est)
72%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.5M | 31 | 3% | N/A |
#2 | $4.3M | 31 | 7% | N/A |
#3 | $5.1M | 31 | 19% | N/A |
#4 | $6.7M | 31 | 29% | N/A |
#5 | $6.7M | 31 | -6% | N/A |